Already on a GLP-1 — and Paying Too Much?
If you’re on Medicare and paying full price for a weight-management GLP-1, here’s a plain-language guide to navigating the switch to the Bridge — about $50 a month.
First, check your drug
The Bridge covers only three products, for weight management:
Foundayo · pillWegovy · injection & tabletsZepbound · KwikPen only
On Wegovy? You’re on a covered drug — ask about moving to the Bridge price.
On Zepbound vials or single-dose pens? Only the KwikPen is covered — ask your provider about switching forms.
On Ozempic? Not covered here — it’s approved for diabetes, not weight. Ask which path fits you.
You still need to qualify
Switching isn’t automatic — you meet the same two checks (though your diagnosis may already be documented):
● Coverage: a 2026 Part D or Medicare Advantage drug plan.
● Medical (meet one): BMI 35+; or BMI 30+ with heart failure, uncontrolled high blood pressure, or chronic kidney disease; or BMI 27+ with prediabetes, a past heart attack, a past stroke, or symptomatic peripheral artery disease.
How to switch to the $50 price
- Tell your provider you want to move to “the Medicare GLP-1 Bridge,” by name.
- They send a new prescription for a covered drug through the Bridge — it does not run on your regular drug card.
- The first claim is rejected on purpose to trigger a prior authorization. It is not a denial.
- Your provider submits it; a decision usually comes within 72 hours.
- You pick up your refill for about $50. Future refills need no new approval.
Good to know about cost
- The savings are real — but the $50 does not count toward your Part D deductible, the “donut hole,” or your yearly out-of-pocket maximum.
- “Extra Help” does not lower it.
- Cash-discount sites (like TrumpRx) exclude Medicare members — the Bridge is your route.
Unassisted Living is an independent editorial publication — not medical, insurance, or financial advice, and not an endorsement of any medication, treatment, provider, or plan. Never stop or change a medication without talking to your provider. Program terms, including the Dec 31, 2027 end date, are subject to change; only your provider and Medicare can confirm what applies to you. Sources: CMS.gov and Medicare.gov/glp1bridge. Reviewed June 2026.